Abstract:Background: Increasing evidence indicates that oxidative stress and interferon γ (IFNγ)-driven cellular immune responses are responsible for the pathogenesis of vitiligo. However, the connection between oxidative stress and the local production of IFNγ in early vitiligo remains unexplored. The aim of this study was to identify the mechanism underlying the production of IFNγ by mast cells and its impact on vitiligo pathogenesis. Methods: Skin specimens from the central, marginal, and perilesional skin areas of active vitiligo lesions were collected to characterize changes of mast cells, CD8+ T cells, and IFNγ-producing cells. Cell supernatants from hydrogen peroxide (H2O2)-treated keratinocytes (KCs) were harvested to measure levels of soluble stem cell factor (sSCF) and matrix metalloproteinase (MMP)-9. A murine vitiligo model was established using Mas-related G protein-coupled receptor-B2 (MrgB2, mouse ortholog of human MrgX2) conditional knockout (MrgB2-/-) mice to investigate IFNγ production and inflammatory cell infiltrations in tail skin following the challenge with tyrosinase-related protein (Tyrp)-2 180 peptide. Potential interactions between the Tyrp-2 180 peptide and MrgX2 were predicted using molecular docking. The siRNAs targeting MrgX2 and the calcineurin inhibitor FK506 were also used to examine the signaling pathways involved in mast cell activation. Results: IFNγ-producing mast cells were closely aligned with the recruitment of CD8+ T cells in the early phase of vitiligo skin. sSCF released by KCs through stress-enhanced MMP9-dependent proteolytic cleavage recruited mast cells into sites of inflamed skin (Perilesion vs. lesion, 13.00 ± 4.00/HPF vs. 26.60 ± 5.72/HPF, P <0.05). Moreover, IFNγ-producing mast cells were also observed in mouse tail skin following challenge with Tyrp-2 180 (0 h vs. 48 h post-recall, 0.00 ± 0.00/HPF vs. 3.80 ± 1.92/HPF, P <0.05). The IFNγ+ mast cell and CD8+ T cell counts were lower in the skin of MrgB2-/-mice than in those of wild-type mice (WT vs. KO 48 h post-recall, 4.20 ± 0.84/HPF vs. 0.80 ± 0.84/HPF, P <0.05). Conclusion: Mast cells activated by MrgX2 serve as a local IFNγ producer that bridges between innate and adaptive immune responses against MCs in early vitiligo. Targeting MrgX2-mediated mast cell activation may represent a new strategy for treating vitiligo.

Mechanism of CD8+T cells killing melanocytes in the patients with vitiligo

DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10

Mechanisms of melanocyte death in vitiligo

Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion

1205 MIF-inhibition Ameliorates Vitiligo by Suppressing CD8+T Cell Activation and Proliferation

The fate of melanocyte: Mechanisms of cell death in vitiligo

Targeting the Elevated IFN-γ in Vitiligo Patients by Human Anti- IFN-γ Monoclonal Antibody Hampers Direct Cytototoxicity in Melanocyte

Acceleration of Melanocyte Senescence by the Proinflammatory Cytokines IFNγ and TNFα Impairs the Repigmentation Response of Vitiligo Patients to Narrowband Ultraviolet B (NBUVB) Phototherapy

MIF Inhibition Alleviates Vitiligo Progression by Suppressing CD8+ T Cell Activation and Proliferation

Effects of immune microenvironment on the expression of CXCL10 in melanocytes of vitiligo

MicroRNA‑155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo

Analysis of CD8+ TCRβ Chain repertoire in peripheral blood of vitiligo via high-throughput sequencing.

Involvement of interferon γ-producing mast cells in immune responses against melanocytes in vitiligo requires MrgX2 activation

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo

Increased Expression of Toll-like Receptor 7 and 9 in Vitiligo Melanocytes: a Pilot Study

Detection and Significance of CD4+CD25+ Foxp3+ Regulatory T Cells in the Peripheral Blood of Patients with Vitiligo

Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients

Increased Splicing of CXCR3 Isoform B (CXCR3B) by Impaired NRF2 Signaling Leads to Melanocyte Apoptosis in Active Vitiligo

Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo

LL37‐DNA Complex Drives Vitiligo Progression Through TLR9‐MyD88 Signaling Pathways

Vitiligo: Mechanisms of Pathogenesis and Treatment